• English
    • Deutsch
View Item 
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  • English 
    • English
    • Deutsch
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG

Erstveröffentlichung
2013
Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors
Schnaiter, Andrea
Paschka, Peter
Rossi, Marianna
Zenz, Thorsten
Buehler, Andreas
et al.
Faculties
Medizinische Fakultät
Institutions
UKU. Klinik für Innere Medizin III
Published in
Blood ; 122 (2013), 7. - S. 1266-1270. - ISSN 0006-4971
Link to publication
https://dx.doi.org/10.1182/blood-2013-03-488197
Funding information
Else Kroner Fresenius Stiftung (Else Kroner Forschungskolleg Ulm)
CLL Global Research Foundation (Alliance)
Virtual Helmholtz Institute [VH-VI-404, TP2]
DFG [SFB 1074]
Keywords
chronic lymphocytic-leukemia; genomic aberrations; follow-up; survival; progression; prognosis; disease; risk
Dewey Decimal Group
DDC 610 / Medicine & health

Metadata
Show full item record

About OPARU | Contact Us |
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFundingThis CollectionFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFunding

My Account

LoginRegister

Statistics

View Usage Statistics

About OPARU | Contact Us |
Impressum | Privacy statement